
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cross-reactive CD4 + T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
Lucie Loyal, Julian Braun, Larissa Henze, et al.
Science (2021) Vol. 374, Iss. 6564
Open Access | Times Cited: 275
Lucie Loyal, Julian Braun, Larissa Henze, et al.
Science (2021) Vol. 374, Iss. 6564
Open Access | Times Cited: 275
Showing 1-25 of 275 citing articles:
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
Leo Swadling, Mariana O. Diniz, Nathalie Schmidt, et al.
Nature (2021) Vol. 601, Iss. 7891, pp. 110-117
Open Access | Times Cited: 356
Leo Swadling, Mariana O. Diniz, Nathalie Schmidt, et al.
Nature (2021) Vol. 601, Iss. 7891, pp. 110-117
Open Access | Times Cited: 356
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans
Philip A. Mudd, Anastasia A. Minervina, Mikhail V. Pogorelyy, et al.
Cell (2021) Vol. 185, Iss. 4, pp. 603-613.e15
Open Access | Times Cited: 251
Philip A. Mudd, Anastasia A. Minervina, Mikhail V. Pogorelyy, et al.
Cell (2021) Vol. 185, Iss. 4, pp. 603-613.e15
Open Access | Times Cited: 251
Correlates of protection against SARS ‐CoV ‐2 infection and COVID‐19 disease
David Goldblatt, Galit Alter, Shane Crotty, et al.
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 6-26
Open Access | Times Cited: 233
David Goldblatt, Galit Alter, Shane Crotty, et al.
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 6-26
Open Access | Times Cited: 233
Immunological memory to SARS‐CoV ‐2 infection and COVID ‐19 vaccines
Alessandro Sette, Shane Crotty
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 27-46
Open Access | Times Cited: 214
Alessandro Sette, Shane Crotty
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 27-46
Open Access | Times Cited: 214
BNT162b2 vaccination induces durable SARS-CoV-2–specific T cells with a stem cell memory phenotype
Gisella Guerrera, Mario Picozza, Silvia D’Orso, et al.
Science Immunology (2021) Vol. 6, Iss. 66
Open Access | Times Cited: 200
Gisella Guerrera, Mario Picozza, Silvia D’Orso, et al.
Science Immunology (2021) Vol. 6, Iss. 66
Open Access | Times Cited: 200
Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19
Keith Sacco, Riccardo Castagnoli, Svetlana Vakkilainen, et al.
Nature Medicine (2022) Vol. 28, Iss. 5, pp. 1050-1062
Open Access | Times Cited: 193
Keith Sacco, Riccardo Castagnoli, Svetlana Vakkilainen, et al.
Nature Medicine (2022) Vol. 28, Iss. 5, pp. 1050-1062
Open Access | Times Cited: 193
Count on us: T cells in SARS-CoV-2 infection and vaccination
Katherine Kedzierska, Paul G. Thomas
Cell Reports Medicine (2022) Vol. 3, Iss. 3, pp. 100562-100562
Open Access | Times Cited: 116
Katherine Kedzierska, Paul G. Thomas
Cell Reports Medicine (2022) Vol. 3, Iss. 3, pp. 100562-100562
Open Access | Times Cited: 116
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
Sam M. Murray, M. Azim Ansari, John Frater, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 5, pp. 304-316
Open Access | Times Cited: 114
Sam M. Murray, M. Azim Ansari, John Frater, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 5, pp. 304-316
Open Access | Times Cited: 114
T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 114
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 114
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
Antonio Bertoletti, Nina Le Bert, Anthony T. Tan
Immunity (2022) Vol. 55, Iss. 10, pp. 1764-1778
Open Access | Times Cited: 92
Antonio Bertoletti, Nina Le Bert, Anthony T. Tan
Immunity (2022) Vol. 55, Iss. 10, pp. 1764-1778
Open Access | Times Cited: 92
The Remarkable Evolutionary Plasticity of Coronaviruses by Mutation and Recombination: Insights for the COVID-19 Pandemic and the Future Evolutionary Paths of SARS-CoV-2
Grigoris D. Amoutzias, Marios Nikolaidis, Eleni Tryfonopoulou, et al.
Viruses (2022) Vol. 14, Iss. 1, pp. 78-78
Open Access | Times Cited: 82
Grigoris D. Amoutzias, Marios Nikolaidis, Eleni Tryfonopoulou, et al.
Viruses (2022) Vol. 14, Iss. 1, pp. 78-78
Open Access | Times Cited: 82
Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients
Eva Schrezenmeier, Héctor Rincón-Arévalo, Annika Jens, et al.
JCI Insight (2022) Vol. 7, Iss. 9
Open Access | Times Cited: 80
Eva Schrezenmeier, Héctor Rincón-Arévalo, Annika Jens, et al.
JCI Insight (2022) Vol. 7, Iss. 9
Open Access | Times Cited: 80
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 66
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 66
Improved predictions of antigen presentation and TCR recognition with MixMHCpred2.2 and PRIME2.0 reveal potent SARS-CoV-2 CD8+ T-cell epitopes
David Gfeller, Julien Schmidt, Giancarlo Croce, et al.
Cell Systems (2023) Vol. 14, Iss. 1, pp. 72-83.e5
Open Access | Times Cited: 58
David Gfeller, Julien Schmidt, Giancarlo Croce, et al.
Cell Systems (2023) Vol. 14, Iss. 1, pp. 72-83.e5
Open Access | Times Cited: 58
SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection
Jernej Pušnik, Werner O. Monzon-Posadas, Jasmin Zorn, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
Jernej Pušnik, Werner O. Monzon-Posadas, Jasmin Zorn, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
Functional SARS-CoV-2 cross-reactive CD4 + T cells established in early childhood decline with age
Marion Humbert, Anna Olofsson, David Wullimann, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 12
Open Access | Times Cited: 41
Marion Humbert, Anna Olofsson, David Wullimann, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 12
Open Access | Times Cited: 41
Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variant
Rofhiwa Nesamari, Millicent A. Omondi, Richard Baguma, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 2, pp. 162-169.e3
Open Access | Times Cited: 27
Rofhiwa Nesamari, Millicent A. Omondi, Richard Baguma, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 2, pp. 162-169.e3
Open Access | Times Cited: 27
Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice
Rúbens Prince dos Santos Alves, Julia Timis, Robyn Miller, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Rúbens Prince dos Santos Alves, Julia Timis, Robyn Miller, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Hybrid immunity-based induction of durable pan-endemic-coronavirus immunity in the elderly
Lucie Loyal, Julian Braun, Ulf Reimer, et al.
Cell Reports (2025) Vol. 44, Iss. 2, pp. 115314-115314
Open Access | Times Cited: 1
Lucie Loyal, Julian Braun, Ulf Reimer, et al.
Cell Reports (2025) Vol. 44, Iss. 2, pp. 115314-115314
Open Access | Times Cited: 1
The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?
Rosemary J. Boyton, Daniel M. Altmann
Nature reviews. Immunology (2021) Vol. 21, Iss. 12, pp. 762-768
Open Access | Times Cited: 98
Rosemary J. Boyton, Daniel M. Altmann
Nature reviews. Immunology (2021) Vol. 21, Iss. 12, pp. 762-768
Open Access | Times Cited: 98
Identification of resident memory CD8 + T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue
Julia Niessl, Takuya Sekine, Joshua Lange, et al.
Science Immunology (2021) Vol. 6, Iss. 64
Open Access | Times Cited: 80
Julia Niessl, Takuya Sekine, Joshua Lange, et al.
Science Immunology (2021) Vol. 6, Iss. 64
Open Access | Times Cited: 80
T cell immunity to SARS-CoV-2
Julia Niessl, Takuya Sekine, Marcus Buggert
Seminars in Immunology (2021) Vol. 55, pp. 101505-101505
Open Access | Times Cited: 71
Julia Niessl, Takuya Sekine, Marcus Buggert
Seminars in Immunology (2021) Vol. 55, pp. 101505-101505
Open Access | Times Cited: 71
Induction of robust cellular and humoral immunity against SARS-CoV-2 after a third dose of BNT162b2 vaccine in previously unresponsive older adults
Addi J. Romero‐Olmedo, Axel Schulz, Svenja Hochstätter, et al.
Nature Microbiology (2022) Vol. 7, Iss. 2, pp. 195-199
Open Access | Times Cited: 63
Addi J. Romero‐Olmedo, Axel Schulz, Svenja Hochstätter, et al.
Nature Microbiology (2022) Vol. 7, Iss. 2, pp. 195-199
Open Access | Times Cited: 63
Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination
Yacine Maringer, Annika Nelde, Sarah M. Schroeder, et al.
Science Immunology (2022) Vol. 7, Iss. 78
Open Access | Times Cited: 61
Yacine Maringer, Annika Nelde, Sarah M. Schroeder, et al.
Science Immunology (2022) Vol. 7, Iss. 78
Open Access | Times Cited: 61
Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination
Yu Gao, Curtis Cai, David Wullimann, et al.
Immunity (2022) Vol. 55, Iss. 9, pp. 1732-1746.e5
Open Access | Times Cited: 59
Yu Gao, Curtis Cai, David Wullimann, et al.
Immunity (2022) Vol. 55, Iss. 9, pp. 1732-1746.e5
Open Access | Times Cited: 59